Evidence and Perspectives on the 24-hour Management of Hypertension: Hemodynamic Biomarker-Initiated ‘Anticipation Medicine’ for Zero Cardiovascular Event

Progress in Cardiovascular Diseases

Volumn 59, Issue 3, 2016, Pages 262-281

  Kario, Kazuomi ^a,b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Hypertension Cardiovascular Outcome Prevention and Evidence in Asia (HOPE Asia) Network   (Japan)

Author keywords

Ambulatory blood pressure monitoring; Anticipation medicine; Blood pressure variability; Home blood pressure monitoring; Information and communication technology; Morning hypertension; Nocturnal hypertension; Perfect 24 h blood pressure control; Systemic hemodynamic atherothrombotic syndrome; Wearable blood pressure monitoring

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; AMLODIPINE PLUS TELMISARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; AZILSARTAN; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CHLORTALIDONE; DIURETIC AGENT; DOXAZOSIN; HYDROCHLOROTHIAZIDE; VALSARTAN;

ANTICIPATION MEDICINE; ARTERIAL STIFFNESS; ATRIAL FIBRILLATION; BEDTIME DOSAGE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CARDIO ANKLE VASCULAR INDEX; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COMBINATION DRUG THERAPY; DIABETIC HYPERTENSION; DOSAGE SCHEDULE COMPARISON; ETHNIC DIFFERENCE; HOME MONITORING; HUMAN; HYPERTENSION; HYPOTHESIS; INFORMATION TECHNOLOGY; KIDNEY DENERVATION; LOW DRUG DOSE; MORNING DOSAGE; PERSONALIZED MEDICINE; PROGNOSTIC ASSESSMENT; PULSE WAVE; RESONANCE HYPOTHESIS; REVIEW; RISK ASSESSMENT; SODIUM RESTRICTION; SYSTEMIC HEMODYNAMIC ATHEROTHROMBOTIC SYNDROME; THROMBOSIS; TONOMETRY; WHITE COAT HYPERTENSION; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CIRCADIAN RHYTHM; DISEASE MANAGEMENT; ETHNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DISEASE MANAGEMENT; HUMANS; HYPERTENSION;

EID: 84965057078     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2016.04.001     Document Type: Review

References (123)

1. 1. Shimamoto, K., Ando, K., Fujita, T., et al. Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 37 (2014), 253–387.
2. 2. Kario, K., Proposal of a new strategy for ambulatory blood pressure profile-based management of resistant hypertension in the era of renal denervation. Hypertens Res 36 (2013), 478–484.
3. 3. Park, J.B., Kario, K., Wang, J.G., Systolic hypertension: An increasing clinical challenge in Asia. Hypertens Res 38 (2015), 227–236.
4. 4. Ueshima, H., Sekikawa, A., Miura, K., et al. Cardiovascular disease and risk factors in Asia: A selected review. Circulation 118 (2008), 2702–2709.
5. 5. Kario, K., Saito, I., Kushiro, T., et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: Primary results of HONEST, a large-scale prospective, real-world observational study. Hypertension 64 (2014), 989–996.
6. 6. Lawes, C.M., Bennett, D.A., Parag, V., et al. Blood pressure indices and cardiovascular disease in the Asia Pacific region: A pooled analysis. Hypertension 42 (2003), 69–75.
7. 7. Katsuya, T., Ishikawa, K., Sugimoto, K., Rakugi, H., Ogihara, T., Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res 26 (2003), 521–525.
8. 8. Ishikawa, Y., Ishikawa, J., Ishikawa, S., et al. Prevalence and determinants of prehypertension in a Japanese general population: The Jichi Medical School Cohort study. Hypertens Res 31 (2008), 1323–1330.
9. 9. Ishikawa, Y., Ishikawa, J., Ishikawa, S., et al. Prehypertension and the risk for cardiovascular disease in the Japanese general population: The Jichi Medical School Cohort study. J Hypertens 28 (2010), 1630–1637.
10. 10. Hoshide, S., Kario, K., de la Sierra, A., et al. Ethnic differences in the degree of morning blood pressure surge and in its determinants between Japanese and European hypertensive subjects: Data from the ARTEMIS study. Hypertension 66 (2015), 750–756.
11. 11. Kario, K., Benefits of strict blood-pressure lowering in hypertension. Nat Rev Cardiol 13 (2016), 125–126.
12. 12. Bangalore, S., Kumar, S., Lobach, I., Messerli, F.H., Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: Observations from traditional and bayesian random-effects meta-analyses of randomized trials. Circulation 123 (2011), 2799–2810.
13. 13. Mancia, G., Fagard, R., Narkiewicz, K., et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31 (2013), 1281–1357.
14. 14. Weber, M.A., Schiffrin, E.L., White, W.B., et al. Clinical practice guidelines for the management of hypertension in the community: A statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens 16 (2014), 14–26.
15. 15. SPRINT Research Group, Wright, J.T. Jr., Williamson, J.D., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373 (2015), 2103–2116.
16. 16. ACCORD Study Group, Cushman, W.C., Evans, G.W., et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362 (2010), 1575–1585.
17. 17. Benavente, O.R., Coffey, C.S., Conwit, R., et al. Blood-pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial. Lancet 382 (2013), 507–515.
18. 18. Ettehad, D., Emdin, C.A., Kiran, A., et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet, 2015, 10.1016/S0140-6736(15)01225-8.
19. 19. Kario, K., Essential Manual of 24-hour Blood Pressure Management from Morning to Nocturnal Hypertension. 2015, Wiley-Blackwell, London, UK, 1–138.
20. 20. Pickering, T.G., Shimbo, D., Haas, D., Ambulatory blood-pressure monitoring. N Engl J Med 354 (2006), 2368–2374.
21. 21. O'Brien, E., Parati, G., Stergiou, G., et al. European society of hypertension working group on blood pressure monitoring. European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 31 (2013), 1731–1768.
22. 22. Kario, K., Shimada, K., Schwartz, J.E., Matsuo, T., Hoshide, S., Pickering, T.G., Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 38 (2001), 238–245.
23. 23. Verdecchia, P., Reboldi, G.P., Angeli, F., et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 45 (2005), 203–208.
24. 24. Ohkubo, T., Kikuya, M., Metoki, H., et al. Prognosis of “masked” hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 46 (2005), 508–515.
25. 25. Myers, M.G., Kaczorowski, J., Paterson, J.M., Dolovich, L., Tu, K., Thresholds for diagnosing hypertension based on automated office blood pressure measurements and cardiovascular risk. Hypertension 66 (2015), 489–495.
26. 26. Parati, G., Stergiou, G.S., Asmar, R., et al. ESH working group on blood pressure monitoring. European society of hypertension guidelines for blood pressure monitoring at home: A summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 26 (2008), 1505–1526.
27. 27. Kario, K., Saito, I., Kushiro, T., et al. Morning home blood pressure is a strong predictor of coronary artery disease: The HONEST study. J Am Coll Cardiol 67 (2016), 1519–1527.
28. 28. Asayama, K., Ohkubo, T., Metoki, H., et al. Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP). Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure. Hypertens Res 35 (2012), 1102–1110.
29. 29. Kario, K., Clinician's Manual on Early Morning Risk Management in Hypertension. 2004, Science Press, London, UK, 1–68.
30. 30. Kario, K., Ishikawa, J., Pickering, T.G., et al. Morning hypertension: The strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res 29 (2006), 581–587.
31. 31. Kario, K., Matsui, Y., Shibasaki, S., et al. An alpha-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: The Japan Morning Surge-1 study. J Hypertens 26 (2008), 1257–1265.
32. 32. Kario, K., Bhatt, D.L., Brar, S., Cohen, S.A., Fahy, M., Bakris, G.L., Effect of catheter-based renal denervation on morning and nocturnal blood pressure. Insights from SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan. Hypertension 66 (2015), 1130–1137.
33. 33. Kario, K., Pickering, T.G., Umeda, Y., et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation 107 (2003), 1401–1406.
34. 34. Kario, K., Morning surge in blood pressure and cardiovascular risk: Evidence and perspectives. Hypertension 56 (2010), 765–773.
35. 35. Li, Y., Thijs, L., Hansen, T.W., et al. International database on ambulatory blood pressure monitoring in relation to cardiovascular outcomes investigators. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension 55 (2010), 1040–1048.
36. 36. Kario, K., Prognosis in relation to blood pressure variability: Pro side of the argument. Hypertension 65 (2015), 1163–1169.
37. 37. Boggia, J., Li, Y., Thijs, L., et al. International database on ambulatory blood pressure monitoring in relation to cardiovascular outcomes (IDACO) investigators. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 370 (2007), 1219–1229.
38. 38. Hoshide, S., Ishikawa, J., Eguchi, K., Ojima, T., Shimada, K., Kario, K., Masked nocturnal hypertension and target organ damage in hypertensives with well-controlled self-measured home blood pressure. Hypertens Res 30 (2007), 143–149.
39. 39. Komori, T., Eguchi, K., Tomizawa, H., et al. Factors associated with incident ischemic stroke in hospitalized heart failure patients: A pilot study. Hypertens Res 31 (2008), 289–294.
40. 40. Li, Y., Staessen, J.A., Lu, L., Li, L.H., Wang, G.L., Wang, J.G., Is isolated nocturnal hypertension a novel clinical entity? Findings from a Chinese population study. Hypertension 50 (2007), 333–339.
41. 41. Matsui, Y., Eguchi, K., O'Rourke, M.F., et al. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients. Hypertension 54 (2009), 716–723.
42. 42. Eguchi, K., Hoshide, S., Kabutoya, T., Shimada, K., Kario, K., Is very low dose hydrochlorothiazide combined with candesartan effective in uncontrolled hypertensive patients?. Blood Press Monit 15 (2010), 308–311.
43. 43. Kario, K., Obstructive sleep apnea syndrome and hypertension: Ambulatory blood pressure. Hypertens Res 32 (2009), 428–432.
44. 44. Kario, K., Kuwabara, M., Hoshide, S., Nagai, M., Shimpo, M., Effects of nighttime single-dose administration of vasodilating vs. sympatholytic antihypertensive agents on sleep blood pressure in hypertensive patients with sleep apnea syndrome. J Clin Hypertens 16 (2014), 459–466.
45. 45. Kario, K., Pickering, T.G., Matsuo, T., Hoshide, S., Schwartz, J.E., Shimada, K., Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 38 (2001), 852–857.
46. 46. Kario, K., Matsuo, T., Kobayashi, H., Imiya, M., Matsuo, M., Shimada, K., Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 27 (1996), 130–135.
47. 47. Hoshide, S., Kario, K., Hoshide, Y., et al. Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens 16 (2003), 434–438.
48. 48. Ohkubo, T., Hozawa, A., Yamaguchi, J., et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: The Ohasama study. J Hypertens 20 (2002), 2183–2189.
49. 49. Kario, K., Schwartz, J.E., Davidson, K.W., Pickering, T.G., Gender differences in associations of diurnal blood pressure variation, awake physical activity and sleep quality with negative affect: The Work Site Blood Pressure study. Hypertension 38 (2001), 997–1002.
50. 50. Viera, A.J., Lin, F.C., Hinderliter, A.L., et al. Nighttime blood pressure dipping in young adults and coronary artery calcium 10–15 years later: The coronary artery risk development in young adults study. Hypertension 59 (2012), 1157–1163.
51. 51. Komori, T., Eguchi, K., Saito, T., Nishimura, Y., Hoshide, S., Kario, K., Riser blood pressure pattern is associated with mild cognitive impairment in heart failure patients. Am J Hypertens 29 (2016), 194–201.
52. 52. Komori, T., Eguchi, K., Saito, T., Hoshide, S., Kario, K., Riser pattern, another determinant of heart failure with preserved ejection fraction. J Clin Hypertens, 2016 [in press].
53. 53. Salles, G.F., Reboldi, G., Fagard, RH, et al. The ABC-H investigators. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients; the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension 67 (2016), 693–700.
54. 54. Palatini, P., Reboldi, G., Beilin, L.J., et al. Added predictive value of night-time blood pressure variability for cardiovascular events and mortality: The Ambulatory Blood Pressure-International study. Hypertension 64 (2014), 487–493.
55. 55. Kabutoya, T., Hoshide, S., Ishikawa, J., Eguchi, K., Shimada, K., Kario, K., The effect of pulse rate and blood pressure dipping status on the risk of stroke and cardiovascular disease in Japanese hypertensive patients. Am J Hypertens 23 (2010), 749–755.
56. 56. Ruilope, L.M., Dukat, A., Böhm, M., Lacourcière, Y., Gong, J., Lefkowitz, M.P., Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study. Lancet 375 (2010), 1255–1266.
57. 57. Kario, K., Sun, N., Chiang, F.T., et al. Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study. Hypertension 63 (2014), 698–705.
58. 58. Bavishi, C., Messerli, F.H., Kadosh, B., Ruilope, L.M., Kario, K., Role of neprilysin inhibitor combinations in hypertension: Insights from hypertension and heart failure trials. Eur Heart J 36 (2015), 1967–1973.
59. 59. McMurray, J.J., Packer, M., Desai, A.S., et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371 (2014), 993–1004.
60. 60. Zinman, B., Wanner, C., Lachin, J.M., et al. Empagliflozin, cardiovascular outcomes, and mortality in Type 2 diabetes. N Engl J Med 373 (2015), 2117–2128.
61. 61. Imaizumi, Y., Eguchi, K., Murakami, T., Arakawa, K., Tsuchihashi, T., Kario, K., High salt intake is independently associated with hypertensive target organ damage. J Clin Hypertens 18 (2016), 315–321.
62. 62. Nakano, M., Eguchi, K., Sato, T., Onoguchi, A., Hoshide, S., Kario, K., Effect of intensive salt-restriction education on clinic, home, and ambulatory blood pressure levels in treated hypertensive patients during a 3-month education period. J Clin Hypertens, 2016 [in press].
63. 63. Hoshide, S., Kario, K., Yano, Y., et al. Association of morning and evening blood pressure at home with asymptomatic organ damage in the J-HOP study. Am J Hypertens 27 (2014), 939–947.
64. 64. Wang, J.G., Kario, K., Lau, T., et al. Asian Pacific Heart Association. Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: A scientific statement from the Asian Pacific Heart Association. Hypertens Res 34 (2011), 423–430.
65. 65. Eguchi, K., Kario, K., Hoshide, Y., et al. Comparison of valsartan and amlodipine on ambulatory and morning blood pressure in hypertensive patients. Am J Hypertens 17 (2004), 112–117.
66. 66. Kario, K., Hoshide, S., Age-related difference in the sleep pressure-lowering effect between an angiotensin II receptor blocker and a calcium channel blocker in Asian hypertensives: The ACS1 study. Hypertension 65 (2015), 729–735.
67. 67. Kario, K., Hoshide, S., Age- and sex-related differences in efficacy with an angiotensin II receptor blocker and a calcium channel blocker in Asian hypertensive patients. J Clin Hypertens, 2015 [in press].
68. 68. Pareek, A.K., Messerli, F.H., Chandurkar, N.B., et al. Efficacy of low-dose chlorthalidone and hydrochlorothiazide as assessed by 24-h ambulatory blood pressure monitoring. J Am Coll Cardiol 67 (2016), 379–389.
69. 69. Kario, K., Proposal of RAS-diuretic vs. RAS-calcium antagonist strategies in high-risk hypertension: Insight from the 24-hour ambulatory blood pressure profile and central pressure. J Am Soc Hypertens 4 (2010), 215–218.
70. 70. Kario, K., Hoshide, S., Shimizu, M., et al. Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: The Japan Morning Surge-Target Organ Protection (J-TOP) study. J Hypertens 28 (2010), 1574–1583.
71. 71. Kario, K., Hoshide, S., Uchiyama, K., et al. Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation. J Clin Hypertens, 2016 [in press].
72. 72. Bhatt, D.L., Kandzari, D.E., O'Neill, W.W., et al. SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370 (2014), 1393–1401.
73. 73. Kario, K., Ogawa, H., Okumura, K., et al. SYMPLICITY HTN-Japan Investigators. SYMPLICITY HTN-Japan – First randomized controlled trial of catheter-based renal denervation in Asian patients. Circ J 79 (2015), 1222–1229.
74. 74. Kandzari, D., Kario, K., Mahfoud, F., et al. The SPYRAL HTN global clinical trial program: Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications. Am Heart J 171 (2016), 82–91.
75. 75. Collins, F.S., Varmus, H., A new initiative on precision medicine. N Engl J Med 372 (2015), 793–795.
76. 76. Parati, G., Ochoa, J.E., Lombardi, C., Bilo, G., Assessment and management of blood-pressure variability. Nat Rev Cardiol 10 (2013), 143–155.
77. 77. Kikuya, M., Ohkubo, T., Metoki, H., et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: The Ohasama study. Hypertension 52 (2008), 1045–1050.
78. 78. Eguchi, K., Ishikawa, J., Hoshide, S., et al. Night time blood pressure variability is a strong predictor for cardiovascular events in patients with type 2 diabetes. Am J Hypertens 22 (2009), 46–51.
79. 79. Rothwell, P.M., Howard, S.C., Dolan, E., et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375 (2010), 895–905.
80. 80. Matsui, Y., O'Rourke, M.F., Hoshide, S., Ishikawa, J., Shimada, K., Kario, K., Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: The Japan Combined Treatment with Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy study. Hypertension 59 (2012), 1132–1138.
81. 81. Nagai, M., Hoshide, S., Ishikawa, J., Shimada, K., Kario, K., Visit-to-visit blood pressure variations: New independent determinants for cognitive function in the elderly at high risk of cardiovascular disease. J Hypertens 30 (2012), 1556–1563.
82. 82. Kawai, T., Ohishi, M., Ito, N., et al. Alteration of vascular function is an important factor in the correlation between visit-to-visit blood pressure variability and cardiovascular disease. J Hypertens 31 (2013), 1387–1395.
83. 83. Fukui, M., Ushigome, E., Tanaka, M., et al. Home blood pressure variability on one occasion is a novel factor associated with arterial stiffness in patients with type 2 diabetes. Hypertens Res 36 (2013), 219–225.
84. 84. Endo, K., Kario, K., Koga, M., et al. Impact of early blood pressure variability on stroke outcomes after thrombolysis: The SAMURAI rt-PA Registry. Stroke 44 (2013), 816–818.
85. 85. Wei, F.F., Li, Y., Zhang, L., et al. Beat-to-beat, reading-to-reading, and day-to-day blood pressure variability in relation to organ damage in untreated Chinese. Hypertension 63 (2014), 790–796.
86. 86. Nagai, M., Hoshide, S., Nishikawa, M., Masahisa, S., Kario, K., Visit-to-visit blood pressure variability in the elderly: Associations with cognitive impairment and carotid artery remodeling. Atherosclerosis 233 (2014), 19–26.
87. 87. Kagitani, H., Hoshide, S., Kario, K., Optimal indicators of home BP variability in perimenopausal women and associations with albuminuria and reproducibility: The J-HOT home BP study. Am J Hypertens 28 (2015), 586–594.
88. 88. Rakugi, H., Ogihara, T., Saruta, T., et al. Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis. J Hypertens 33 (2015), 2165–2172.
89. 89. Shibasaki, S., Hoshide, S., Eguchi, K., Ishikawa, J., Kario, K., Japan Morning Surge-Home Blood Pressure (J-HOP) Study Group. Increase trend in home blood pressure on a single occasion is associated With B-type natriuretic peptide and the estimated glomerular filtration rate. Am J Hypertens 28 (2015), 1098–1105.
90. 90. Kario, K., Eguchi, K., Nakagawa, Y., Motai, K., Shimada, K., Relationship between extreme dippers and orthostatic hypertension in elderly hypertensive patients. Hypertension 31 (1998), 77–82.
91. 91. Kario, K., Eguchi, K., Hoshide, S., et al. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: Orthostatic hypertension as a new cardiovascular risk factor. J Am Coll Cardiol 40 (2002), 133–141.
92. 92. Hoshide, S., Matsui, Y., Shibasaki, S., et al. Orthostatic hypertension detected by self-measured home blood pressure monitoring: A new cardiovascular risk factor for elderly hypertensives. Hypertens Res 31 (2008), 1509–1516.
93. 93. Kario, K., Orthostatic hypertension – A new haemodynamic cardiovascular risk factor. Nat Rev Nephrol 9 (2013), 726–738.
94. 94. Kario, K., Tomitani, N., Matsumoto, Y., et al. Research and development of information and communication technology-based home blood pressure monitoring from morning to nocturnal hypertension. Ann Glob Health, 2016 [in press].
95. 95. Imaizumi, Y., Eguchi, K., Taketomi, A., Tsuchihashi, T., Kario, K., Exaggerated blood pressure variability in patients with pneumoconiosis: A pilot study. Am J Hypertens 27 (2014), 1456–1463.
96. 96. Kayano, H., Koba, S., Matsui, T., et al. Impact of depression on masked hypertension and variability in home blood pressure in treated hypertensive patients. Hypertens Res 38 (2015), 751–757.
97. 97. Umemoto, S., Ogihara, T., Matsuzaki, M., et al. Effects of calcium channel blocker-based combinations on intra-individual blood pressure variability: post hoc analysis of the COPE trial. Hypertens Res 39 (2016), 46–53.
98. 98. Imaizumi, Y., Eguchi, K., Kario, K., Coexistence of PM2.5 and low temperature is associated with morning hypertension in hypertensives. Clin Exp Hypertens 37 (2015), 468–472.
99. 99. Kario, K., New insight of morning blood pressure surge into the triggers of cardiovascular disease-synergistic resonance of blood pressure variability. Am J Hypertens 29 (2016), 14–16.
100. 100. Kario, K., Caution for winter morning surge in blood pressure: A possible link with cardiovascular risk in the elderly. Hypertension 47 (2006), 139–140.
101. 101. Matsui, Y., Ishikawa, J., Eguchi, K., Shibasaki, S., Shimada, K., Kario, K., Maximum value of home blood pressure: A novel indicator of target organ damage in hypertension. Hypertension 57 (2011), 1087–1093.
102. 102. Kario, K., Systemic hemodynamic atherothrombotic syndrome: A blind spot in the current management of hypertension. J Clin Hypertens 17 (2015), 328–331.
103. 103. Kario, K., Hamasaki, H., Nocturnal blood pressure surge behind morning surge in obstructive sleep apnea syndrome: Another phenotype of systemic hemodynamic atherothrombotic syndrome. J Clin Hypertens 17 (2015), 682–685.
104. 104. Ito, S., Nagasawa, T., Abe, M., Mori, T., Strain vessel hypothesis: A viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res 32 (2009), 115–121.
105. 105. Sakamoto, K., Hosokawa, K., Saku, K., et al. Baroreflex failure increases the risk of pulmonary edema in conscious rats with normal left ventricular function. Am J Physiol Heart Circ Physiol 310 (2016), H199–H205.
106. 106. Horinaka, S., Yagi, H., Ishimura, K., et al. Cardio-ankle vascular index (CAVI) correlates with aortic stiffness in the thoracic aorta using ECG-gated multi-detector row computed tomography. Atherosclerosis 235 (2014), 239–245.
107. 107. Kaihara, T., Eguchi, K., Kario, K., Home BP monitoring using a telemonitoring system is effective for controlling BP in a remote island in Japan. J Clin Hypertens 16 (2014), 814–819.
108. 108. Kabutoya, T., Ishikawa, J., Hoshide, S., Eguchi, K., Shimada, K., Kario, K., A home blood pressure monitor equipped with a graphic function facilitates faster blood pressure control than the conventional home blood pressure monitor. J Clin Hypertens 11 (2009), 422–425.
109. 109. Kario, K., Matsuo, T., Shimada, K., Pickering, T.G., Factors associated with the occurrence and magnitude of earthquake-induced increases in blood pressure. Am J Med 111 (2001), 379–384.
110. 110. Kario, K., McEwen, B.S., Pickering, T.G., Disasters and the heart: a review of the effects of earthquake-induced stress on cardiovascular disease. Hypertens Res 26 (2003), 355–367.
111. 111. Kario, K., Disaster hypertension – Its characteristics, mechanism, and management. Circ J 76 (2012), 553–562.
112. 112. Kario, K., Matsuo, T., Ishida, T., Shimada, K., White coat hypertension and the Hanshin-Awaji earthquake. Lancet, 345, 1995, 1365.
113. 113. Kario, K., Nishizawa, M., Hoshide, S., et al. Development of a disaster cardiovascular prevention network. Lancet 378 (2011), 1125–1127.
114. 114. Nishizawa, M., Hoshide, S., Okawara, Y., Shimpo, M., Matsuo, T., Kario, K., aftershock triggers augmented pressor effects in survivors: Follow-up of the Great East Japan Earthquake. Am J Hypertens 28 (2015), 1405–1408.
115. 115. Kario, K., Schwartz, J.E., Pickering, T.G., Ambulatory physical activity as a determinant of diurnal blood pressure variation. Hypertension 34 (1999), 685–691.
116. 116. Ishikawa, J., Hoshide, S., Eguchi, K., Ishikawa, S., Shimada, K., Kario, K., Nighttime home blood pressure and the risk of hypertensive target organ damage. Hypertension 60 (2012), 921–928.
117. 117. Kario, K., Hoshide, S., Haimoto, H., et al. Sleep blood pressure self-measured at home as a novel determinant of organ damage: Japan Morning Surge Home Blood Pressure (J-HOP) study. J Clin Hypertens 17 (2015), 340–348.
118. 118. Shirasaki, O., Kuwabara, M., Saito, M., Tagami, K., Washiya, S., Kario, K., Development and clinical application of a new technique for detecting ‘sleep blood pressure surges’ in sleep apnea patients based on a variable desaturation threshold. Hypertens Res 34 (2011), 922–928.
119. 119. Yoshida, T., Kuwabara, M., Hoshide, S., Kario, K., Recurrence of stroke caused by nocturnal hypoxia-induced blood pressure surge in a young adult male with severe obstructive sleep apnea syndrome. J Am Soc Hypertens 10 (2016), 201–204.
120. 120. Kim, S.H., Lilot, M., Sidhu, K.S., et al. Accuracy and precision of continuous noninvasive arterial pressure monitoring compared with invasive arterial pressure: A systematic review and meta-analysis. Anesthesiology 120 (2014), 1080–1097.
121. 121. Lass, J., Meigas, K., Karai, D., Kattai, R., Kaik, J., Rossmann, M., Continuous blood pressure monitoring during exercise using pulse wave transit time measurement. Conf Proc IEEE Eng Med Biol Soc 3 (2004), 2239–2242.
122. 122. Sharman, J.E., Lim, R., Qasem, A.M., et al. Validation of a generalized transfer function to noninvasively derive central blood pressure during exercise. Hypertension 47 (2006), 1203–1208.
123. 123. Sato, T., Nishinaga, M., Kawamoto, A., Ozawa, T., Takatsuji, H., Accuracy of a continuous blood pressure monitor based on arterial tonometry. Hypertension 21 (1993), 866–874.